Ireland
--:--IST
Priya Life Science Clinical trial register
Trackers› Clinical trials› Setúbal
Clinical trial register · Portugal

Clinical Trials in Setúbal, 2026

Every study on the ClinicalTrials.gov registry that lists a site in Portugal and is open, about to open, active-but-closed, or enrolling by invitation. Filter it, cite it, and take it away as a file.

Download CSV
Source: ClinicalTrials.gov, U.S. National Library of Medicine. Complete coverage — all 1104 matching records held by the registry are in this view. Synced 30 Oct 2026, 03:17 UTC
1104
Studies in scope
all four open statuses
533
Recruiting now
open to new participants
285
Lead sponsors
across recruiting studies
Top sites
Lisbon 689 Porto 537 Coimbra 256 Braga 182 Vila Nova de Gaia 105
Narrow the registerReset
Recruitment status
Phase
Site location
Lisbon689 Porto537 Coimbra256 Braga182 Vila Nova de Gaia105
All 97 locations
Target enrolment
to

Trials with a site in Setúbal

24 of 1104 studies
Download
Status
Study
Lead sponsor
Phase
Enrol
Sites in Portugal
Start
Not yet open
MAFF-CRT: Reducing Sedentary Behaviour in Children
NCT07523945Sedentary Behaviors, Physical Inactivity, Child Health, Lifestyle (Sedentary Behavior and Physical Activity)
Instituto Politécnico de Setúbal
Not applicable
200
Setúbal
2026-11-30
Not yet open
Hospital do Divino Espírito Santo de Ponta Delgada
Phase 3
252
Funchal, Ponta Delgada, Coimbra, Setúbal
2026-08-01
Recruiting
Janssen Research & Development, LLC
Phase 3
644
Braga, Lisbon, Portimão, Setúbal
2026-05-23
Recruiting
Janssen Research & Development, LLC
Phase 3
460
Braga, Lisbon, Portimão, Setúbal, Viana do Castelo
2026-05-22
Active, closed
Novartis Pharmaceuticals
Phase 3
5,700
Coimbra, Guimarães, Setúbal
2026-05-11
Recruiting
Boehringer Ingelheim
Phase 3
286
Almada, Amadora, Braga, Coimbra, Lisbon, Loures, Porto, Setúbal
2026-02-16
Recruiting
Heart Rate Variability Biofeedback in Security Forces
NCT07386951Psychological Distress, Well-Being, Psychological, Burnout
Egas Moniz - Cooperativa de Ensino Superior, CRL
Not applicable
50
Setúbal
2026-01-28
By invitation
Celldex Therapeutics
Phase 3
1,370
Aveiro, Coimbra, Lisbon, Setúbal
2025-11-25
Recruiting
GlaxoSmithKline
Phase 3
981
Loures, Senhora da Hora, Almada, Guarda, Lisbon, Setúbal, Vila Nova de Gaia
2025-06-20
Recruiting
Biogen
Phase 3
454
Carnaxide, Vila Nova de Gaia, Aveiro, Braga, Coimbra, Leiria, Setúbal
2025-05-08
Active, closed
Genmab
Phase 3
191
Coimbra, Matosinhos Municipality, Porto, Setúbal
2024-11-25
Recruiting
Stemline Therapeutics, Inc.
Phase 3
4,220
Loures, Vila Franca de Xira, Porto, Vila Nova de Gaia, Coimbra, Faro, Lisbon, Setúbal
2024-09-27
Active, closed
Zenas BioPharma (USA), LLC
Phase 2
190
Lisbon, Setúbal
2024-09-17
Active, closed
Celldex Therapeutics
Phase 3
963
Aveiro, Braga, Coimbra, Lisbon, Matosinhos Municipality, Porto, Setúbal, Vila Nova de Gaia
2024-07-11
Active, closed
Novo Nordisk A/S
Phase 3
673
Guilhufe - Penafiel, Lisbon, Setúbal
2024-04-01
Recruiting
Novartis Pharmaceuticals
Observational
174
Amadora, Guimarães, Leiria, Lisbon, Matosinhos Municipality, Ponte de Lima, Porto, Setúbal
2023-11-27
Active, closed
Amgen
Phase 3
633
Setúbal, Lisbon, Porto
2023-11-02
Recruiting
Instituto Politécnico de Setúbal
Not applicable
186
Setúbal
2023-04-10
Active, closed
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
NCT05739383Primary Prevention of Atherosclerotic Cardiovascular Disease
Novartis Pharmaceuticals
Phase 3
14,012
Almada, Carnaxide, Coimbra, Lisbon, Matosinhos Municipality, Porto, Santa Maria da Feira, Setúbal
2023-03-09
Recruiting
Dimerix Bioscience Pty Ltd
Phase 3
286
Braga, Carnaxide, Lisbon, Loures, Porto, Setúbal, Vila Franca de Xira, Vila Nova de Gaia
2022-05-30
Active, closed
Assistance Publique - Hôpitaux de Paris
Phase 3
800
Almada, Lisbon, Matosinhos Municipality, Porto, Setúbal
2021-08-04
Active, closed
Novo Nordisk A/S
Phase 3
1,500
Senhora Da Hora, Matosinhos, Almada, Aveiro, Coimbra, Guimarães, Lisbon, Porto, Setúbal
2019-05-08
Active, closed
A Study of Zolbetuximab (IMAB362) Plus CAPOX Compared With Placebo Plus CAPOX as First-line Treatment of Subjects With Claudin (CLDN) 18.2-positive, HER2-negative, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (GLOW).
NCT03653507Locally Advanced Unresectable Gastroesophageal Junction (GEJ) Adenocarcinoma or Cancer, Locally Advanced Unresectable Gastric Adenocarcinoma or Cancer, Metastatic Gastric Adenocarcinoma or Cancer, Metastatic Gastroesophageal Junction (GEJ) Adenocarcinoma
Astellas Pharma Global Development, Inc.
Phase 3
507
Braga, Coimbra, Guimarães, Lisbon, Porto, Santa Maria da Feira, Setúbal, Vila Real
2018-11-28
Rows per page Showing 1–24 of 24
1
Cite this view

Priya Life Science (2026). Clinical trial register: studies with a Portuguese investigative site, filtered. Derived from ClinicalTrials.gov. Retrieved 31 October 2026. https://priyalifescience.com/clinical-trials-portugal/city/set-bal

Query this register directly
GET /api/trials?country=in&status=recruiting&format=json Try it now →

About this register

This register is built from ClinicalTrials.gov, the trial registry run by the U.S. National Library of Medicine. It includes every study on the registry that lists at least one investigative site in Portugal and is recruiting, not yet recruiting, active but no longer recruiting, or enrolling by invitation: 1,104 studies in total at the last sync on 30 Oct 2026, 03:17 UTC. The full list can be downloaded as CSV or queried as JSON through the register API.

This page shows the 24 of those studies with a site in Setúbal.

How many clinical trials are recruiting in Setúbal?

10 of the 24 studies on this page are recruiting new participants as of the 30 Oct 2026, 03:17 UTC sync. A further 2 have not yet opened recruitment, 11 are active but closed to new participants, and 1 are enrolling by invitation only. Eligibility for any study is decided by its study team.

Summary by phase

Studies by phase (Setúbal), 24 studies
PhaseStudiesRecruitingShare
Phase 319779.2%
Not applicable3212.5%
Observational114.2%
Phase 2104.2%

Most active sponsors

Lead sponsors with the most studies (Setúbal)
Lead sponsorStudiesRecruiting
Novartis Pharmaceuticals31
Celldex Therapeutics20
Instituto Politécnico de Setúbal21
Janssen Research & Development, LLC22
Novo Nordisk A/S20
Amgen10
Assistance Publique - Hôpitaux de Paris10
Astellas Pharma Global Development, Inc.10
Biogen11
Boehringer Ingelheim11
Listing here is informational and not medical advice; eligibility is determined by each study team. See also the Ireland, UK, EU, USA and China registers.